EQUITY RESEARCH – ZWACK UNICUM EQUITY NOTE: ZWACK UNICUM Recommendation: HOLD (unchanged) Target price (12M): HUF 17,083 (revised up) 15 Dec 2020 We maintain our HOLD recommendation for Zwack Unicum (Zwack HB; ZWCG.BU) with a Equity Analyst: Orsolya Rátkai new 12M target price of 17,083 HUF/share, revised up from previous 15,407 HUF/share. With better-than-expected revenue and profit figures in the July-September period, Phone: +36 1 374 7270 Zwack gave evidence of its ability to swiftly recover once things normalize. However, it is mild comfort regarding the current business year. The second-wave restrictions Email: implemented in November, hitting on-the-site consumption, endanger on-trade sales
[email protected] again as half of Zwack's revenues come from the restaurant industry. The present restrictions can also be a drag on retail sales of spirits even in the Christmas season as festivities are expected to be disallowed. However, covid vaccines are within reach, which is expected to totally change the landscape. With mass vaccination starting up next year, business as usual may return by the middle of the year/second half of 2021. Considering this, we updated our free cash- flow valuation and dividend discount models, and shifted the forecast horizon by one year. Uncertainties on short-term forecast are still high and the schedule of vaccination in Hungary is yet to be published, adding considerable downside risks to our forecast. On the other hand, if immunization proceeds as it is hoped, domestic tourism and restaurant industry is expected to recover quickly and Zwack will benefit from this development.